Navigation Links
Early Stem Cell Transplant Vital in 'Bubble Boy' Disease
Date:7/31/2014

By
HealthDay Reporter

WEDNESDAY, July 30, 2014 (HealthDay News) -- Babies born with so-called "bubble boy" disease can often be cured with a stem cell transplant, regardless of the donor -- but early treatment is critical, a new study finds.

Severe combined immunodeficiency (SCID), as the condition is medically known, actually refers to a group of rare genetic disorders that all but eliminate the immune system. That leaves children at high risk of severe infections.

The term "bubble boy" became popular after a Texas boy with SCID lived in a plastic bubble to ward off infections. The boy, David Vetter, died in 1984 at the age of 12, after an unsuccessful bone marrow transplant -- an attempt to give him a functioning immune system.

Today, children with SCID have a high chance of survival if they receive an early stem cell transplant, researchers report in the July 31 issue of the New England Journal of Medicine.

In the best-case scenario, a child would get stem cells -- the blood-forming cells within bone marrow -- from a sibling who is a perfect match for certain immune-system genes.

But that's not always an option, partly because kids with SCID are often their parents' first child, said Dr. John Cunningham, director of hematopoietic stem cell transplantation at the University of Chicago Comer Children's Hospital. He was not involved in the study.

In those cases, doctors typically turn to a parent -- who is usually a "half" match, but whose stem cells can be purified to improve the odds of success. Sometimes, stem cells from an unrelated, genetically matched donor can be used.

The good news: Regardless of the donor, children with SCID can frequently be cured, according to the new findings. But early detection and treatment is vital.

"These findings show that if you do these transplants early -- before [the age of] 3.5 months, in a child without infection -- the results are really quite comparable to what you have with a matched sibling," said lead researcher Dr. Richard O'Reilly, chief of the pediatric bone marrow transplant service at Memorial Sloan-Kettering Cancer Center in New York City.

O'Reilly and his colleagues reviewed the cases of 240 infants treated for SCID at 25 U.S. centers between 2000 and 2009. They found that the babies had the best chance of survival if they received a transplant within the first few months of life.

When that happened, 94 percent of children were alive five years later. And survival rates were high -- 77 percent to 93 percent in children without active infections -- even if the donor was not a matched sibling.

If that early time window was missed, infants still had good survival odds if their transplant was done before they developed any infections: Overall, 90 percent were alive five years later, the investigators found.

In contrast, the poorest survival was seen among babies who were older than 3.5 months and had an active infection at the time of their transplant, the study authors noted. Of those 91 children, half died.

"Early diagnosis really makes for the best outcomes," O'Reilly said. "If we focus on that, we might get close to eradicating this."

Early diagnosis is becoming more common because there is now a newborn screening test. In 2010, U.S. health officials recommended that states include SCID in their newborn screening panels. So far, 21 states and the District of Columbia have done so, according to the Immune Deficiency Foundation, a nonprofit that is tracking the trend.

SCID is rare: In the United States, an estimated 40 to 100 babies are born with the condition each year, according to the U.S. National Institutes of Health.

O'Reilly noted that some have questioned whether newborn screening is "worth it."

"I'd say that it is," he said.

Cunningham agreed. "Every state should institute newborn screening, because the outcomes are so good with early transplants," he said.

Once a child has survived five years, it's essentially considered a "cure," Cunningham noted. In the long run, those kids do well, he said -- though some need to keep taking immunoglobulin, either through a monthly IV treatment or more frequent self-injections, to prevent infections.

Researchers are also studying gene therapy for SCID, with some promising results so far.

"Stem cell transplant is the gold standard," Cunningham noted. "Gene therapy would have to come up to that standard."

But even though early transplants are often successful, Cunningham said he thinks there is a place for gene therapy -- and, in general, room for improvement in SCID treatment.

"We don't want to stop at 90 percent survival," he said. "We want to cure 100 percent."

More information

The Immune Deficiency Foundation has more on SCID and newborn screening.

SOURCES: Richard O'Reilly, M.D., chief, pediatric bone marrow transplant service, Memorial Sloan-Kettering Cancer Center, New York City; John Cunningham, M.D., director, hematopoietic stem cell transplantation, University of Chicago Medicine, Comer Children's Hospital, Chicago; July 31, 2014, New England Journal of Medicine


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Soy may help womens hearts if they start early
2. Early Hormone Therapy May Be Safe for Womens Hearts
3. Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety
4. Study helps compare risks of treatments for early esophageal cancer
5. Wearable device for the early detection of common diabetes-related neurological condition
6. Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support
7. Kidney transplant drug halves the early risk of rejection and allows less toxic treatment
8. Early warning sign for babies at risk of autism
9. Parents Death May Raise Risk of Early Death for Grown Children, Study Suggests
10. New Studies Reporting a Higher Incidence of Child Abuse in ADHD and Dyslexia Suggest a Need for Early Medical Treatment, Notes Dr. Harold Levinson
11. Brazil vs. Colombia Tickets in Miami: Ticket Down Reports Huge Demand for Colombia vs. Brazil Tickets at Sun Life Stadium in Miami in Early September
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early Stem Cell Transplant Vital in 'Bubble Boy' Disease
(Date:1/20/2017)... , ... January 20, 2017 , ... Source Vitál Apothecary, ... 100 percent pure essential oils, announced the company had a successful visit to the ... annual ECRM event gives companies that work in the nutritional, sports and health industries ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company ... with school-aged children since the holiday season. , “It happens every year around ... sharing hugs and taking photos, which is the head-to-head gateway that lice need to ...
(Date:1/20/2017)... ... , ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in ... has been life-saving as she has been on the trial for more than ... with ovarian cancer in 2009. She underwent standard chemotherapy but a year later went ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater ... of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than ... her career as an educator interacting with countless women who had little knowledge of ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 20, 2017 Research and Markets has ... Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive ... Segment Forecasts, 2013 - 2024" report to their offering. ... The global clinical ... 2024 Introduction of innovative solutions on the grounds of ...
(Date:1/20/2017)... , January 20, 2017 Stock-Callers.com ... (NASDAQ: SGYP ), Novo Nordisk A/S (NYSE: ... ), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX ... on Thursday, January 19 th , 2017, finishing near its ... Care Index dropped over 0.7%, while shares of health care ...
(Date:1/20/2017)... 2017 Wells Specialty Pharmacy announces the acquisitions and ... in Winter Park, Florida and Pharm-EZ ... Operations have been consolidated into the 3796 Howell Branch Road ... announce that Chad Tomlinson , former Vice President of ... immediately. Mr. Tomlinson is a Graduate of Florida State University ...
Breaking Medicine Technology: